The majority of patients with type 2 diabetes (T2D) have less than ideal metabolic control despite our greater understanding of the underlying pathophysiologic mechanisms of hyperglycemia and the ...
New research reveals that type 2 diabetes doesn’t just raise the risk of heart disease, it physically reshapes the heart ...
Download for updates and be a part of the revolution in Endocrinology and Metabolic Disorders Care @ Type 2 Diabetes Clinical Trials Assessment The Type 2 Diabetes Pipeline Report provides a disease ...
The approval of medicines called “glucagon-like peptide (GLP-1) agonists” has led to major changes in how type 2 diabetes is managed. These medicines work in a different way than other medicines used ...
Having persistently high liver enzyme levels present in early adulthood is a strong predictor of type 2 diabetes risk. Learn ...
In a recent review published in the journal Diabetes Care, Daniel J. Drucker of Lunenfeld-Tanenbaum Research Institute, University of Toronto, evaluated the efficacy and safety of glucagon-like ...
PUNE, India, June 6, 2017 /PRNewswire-iReach/ -- Pharmaceutical latest report of Type 2 Diabetes - Pipeline Review, H1 2017 adds on RnRMarketResearch.com. The report provides an overview of the Type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback